This model involves immunising desmoglein 3 null mice against desmoglein 3 and then transferring splenocytes from the immunised mice to Rag2 null mice, which then produce antidesmoglein 3 and develop symptoms of PV [109]. The gene discussed is DSG3; the disease is acquired polycythemia vera.